Given that Fusobacterium nucleatum (Fn) accelerates the development of colorectal (23) and breast (24) cancers, we used the subcutaneous glioma xenograft mouse model to examine whether it also affects tumor progression in glioma, following the scheme in Fig. 7a. Here, FN1 is linked to glioma.